title: Analysis of the Efficacy and Safety of Recombinant Tissue Plasminogen Activator for Chinese Patients over 80 Years of Age with Acute Ischemic Stroke: A Pilot Study.
authors.affiliation: Department of Neurology, North Sichuan Road Branch of Shanghai First People's Hospital, Shanghai, 200081, China.
authors.forename: Jiandao
authors.initials: J
authors.lastname: Yang
authors.affiliation: Department of Neurology, North Sichuan Road Branch of Shanghai First People's Hospital, Shanghai, 200081, China.|Neuroscience Research Australia, Randwick, NSW, 2031, Australia.
authors.forename: Huazheng
authors.initials: H
authors.lastname: Liang
authors.affiliation: Department of Neurology, North Sichuan Road Branch of Shanghai First People's Hospital, Shanghai, 200081, China.
authors.forename: Yanyan
authors.initials: Y
authors.lastname: Song
authors.affiliation: Department of Neurology, North Sichuan Road Branch of Shanghai First People's Hospital, Shanghai, 200081, China.
authors.forename: Lingda
authors.initials: L
authors.lastname: Shen
authors.affiliation: Department of Neurology, North Sichuan Road Branch of Shanghai First People's Hospital, Shanghai, 200081, China. wangshaoshi@126.com.
authors.forename: Shaoshi
authors.initials: S
authors.lastname: Wang
mesh_terms: D000369:Aged, 80 and over; D044466:Asian People; D002545:Brain Ischemia / Q000150:complications; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010865:Pilot Projects; D012720:Severity of Illness Index; D020521:Stroke / Q000188:drug therapy* / Q000209:etiology; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator